Transplant Genomics Inc. — Form D
Transplant Genomics Inc. of Mansfield, MA, a company, filed a Form D exempt-offering notice with the SEC on 2014-12-05. The offering totals $1.7M, of which $1.7M was reported sold. Industry: Other.
Offering
- Filed: 2014-12-05
- Form: D
- Accession: 0000914760-14-000140
- Industry: Other
- Exemptions: 06b
- Total offering: $1.7M
- Amount sold: $1.7M
- Remaining: $30K
- Minimum investment: $5K
- Investors: 41
- Date of first sale: 2014-11-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-229596
Issuer
- Name: Transplant Genomics Inc.
- CIK: 0001604710
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 905 S. Main Street, Mansfield, MA, 02048
- Phone: 508-337-6200
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Peter Lewis | Executive Officer | Vancouver, A1 |
| Jay Venkatesan | Director | Boston, MA |
| Brett Jensen | Executive Officer | Providence, UT |
| Darren Lee | Executive Officer | Mansfield, MA |
| Stanley Rose | Director | Mansfield, MA |
| Stanley Rose | Executive Officer | Mansfield, MA |
| Roy First | Executive Officer | Mansfield, MA |
| David Kravitz | Director | Mansfield, MA |
| Chris O'Connor | Director | Vancouver, A1 |
| Michael Abecassis | Director | Mansfield, MA |
| Dierdre Pierry | Executive Officer | Brookline, MA |
| Kyle Hart | Executive Officer | Brookline, MA |
| Daniel Salomon | Director | Brookline, MA |
| Daniel Solomon | Director | Brookline, MA |
Other filings by this issuer (9)
More